Al Gores Strategic Moves in Q3 2024 Spotlight on Agilent Technologies with a 2.1 percent Portfolio Impact
TXG Stock | USD 15.90 0.42 2.71% |
Roughly 69 percent of all 10X Genomics' stockholders are curious in acquiring. The analysis of overall sentiment of trading 10X Genomics stock suggests that a large number of investors are confidant at this time. The current market sentiment, together with 10X Genomics' historical and current headlines, can help investors time the market. In addition, many technical investors use 10X Genomics stock news signals to limit their universe of possible portfolio assets.
10X |
Insights into Generation Investment Managements Latest 13F Filing Al Gore s investment firm, Generation Investment Management, has recentl
Read at gurufocus.com
10X Genomics Current Investor Sentiment
Panic Vs Confidence
69
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use 10X Genomics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward 10X Genomics.
News SentimentBullish | Hype SentimentBullish | Insider SentimentDisposing |
10X Genomics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards 10X Genomics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
10X Genomics Historical Investor Sentiment
Investor biases related to 10X Genomics' public news can be used to forecast risks associated with an investment in 10X. The trend in average sentiment can be used to explain how an investor holding 10X can time the market purely based on public headlines and social activities around 10X Genomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
10X Genomics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for 10X Genomics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average 10X Genomics news discussions. The higher the estimate score, the more favorable the investor's outlook on 10X Genomics.
10X Genomics Fundamental Analysis
We analyze 10X Genomics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 10X Genomics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 10X Genomics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
10X Genomics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
10X Genomics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 10X Genomics stock to make a market-neutral strategy. Peer analysis of 10X Genomics could also be used in its relative valuation, which is a method of valuing 10X Genomics by comparing valuation metrics with similar companies.
Peers
10X Genomics Related Equities
SANA | Sana Biotechnology | 9.02 | ||||
HEPA | Hepion Pharmaceuticals | 4.69 | ||||
ELEV | Elevation Oncology | 3.23 | ||||
ENVB | Enveric Biosciences | 3.13 | ||||
IKNA | Ikena Oncology | 2.37 | ||||
BEAM | Beam Therapeutics | 0.63 | ||||
KRYS | Krystal Biotech | 0.26 | ||||
RPRX | Royalty Pharma | 0.23 | ||||
CRBU | Caribou Biosciences | 0.45 | ||||
VERV | Verve Therapeutics | 2.94 |
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |